Prova Education

Engaging the Nursing Community in Treatment of Opioid Use Disorder

Engaging the Nursing Community in Treatment of Opioid Use Disorder

With millions of patients suffering from opioid use disorder, what strategies can nurses and advanced practice nurses use to make a positive impact?

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Participants are encouraged to consult the SAMSHA website, for additional and up to date information.

    Nurses have always played a key role in the treatment of substance use disorders, and with the passage of the Comprehensive Addiction and Recovery Act of 2016 (which extends prescribing authority to NPs within the scope of state laws), their contributions have become even more critical. In today’s discussion, we’ll explore how nurses and nurse practitioners can help expand patient access to needed medications for the treatment of Opioid Use Disorder, or OUD. We’ll also highlight the benefits of employing a collaborative care approach to facilitate access to opioid therapy with buprenorphine in an office-based setting.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Mimi Secor, DNP, FNP-BC, FAANP

    Nurse Practitioner
    Speaker and Consultant

    Mimi Secor, has disclosed that she receives fees for non CME services from Hologic.

    Colleen T. LaBelle MSN, RN-BC, CARN
    Program Director, State Technical Assistance Treatment Expansion Office Based Addiction Treatment (STATE OBAT B)
    Boston Medical Center

    Colleen LaBelle has nothing to disclose.


    • Sean Barrett has nothing to disclose.
    • Quandra Blackeney has nothing to disclose.
    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • David S. Liu has nothing to disclose.
    • Jessica McGrory has nothing to disclose.
    • Ashley Rosenthal has nothing to disclose.
    • Joanna Weston has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Learn the most effective strategy for treatment of OUD patients
    • Name common barriers to obtaining and providing effective OUD treatment
    • Describe the requirements for obtaining a waiver to prescribe buprenorphine
    • Outline ways that a collaborative care model can improve patient outcomes
  • Target Audience

    This activity is designed to meet the educational needs of Nurses.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Omnia-Prova Education Collaborative (TOPEC) and National Institute on Drug Abuse (NIDA). TOPEC is accredited by the ACCME to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Prova Education designs educational activities based on evidence-based medicine, needs and gaps analyses, learner feedback, and more. Its mission is to serve as an innovative and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

    ReachMD Healthcare Image

  • Commercial Support

    This activity has received no commercial support.  Funding has been provided by the joint provider, National Institute for Drug Abuse.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments


We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free